A comparison of patient-reported outcome measures for dupuytren disease: A prospective view

Sanjuán-Cerveró, Rafael; Herrero, D. Gómez; Poquet-Jornet, Jaime E; Peña-Molina, Fernando; Iglesia, Nicolas H. de la; Sanjuan-Arago, Aurora; Vázquez-Ferreiro, Pedro; Carrera-Hueso, Francisco Javier

doi:10.1016/j.bjps.2022.06.024

Cited by 2 publications

(1 citation statement)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Also in a recent systematic review the effect size for the QuickDASH (2 studies with 594 subjects) was 0.54 and 0.64, respectively, and that for the Unité Rheumatologique des Affections de la Main (URAM) scale Table 3 Change in the COPM performance (P) and satisfaction (S) scores between baseline and 5 weeks in the identified activities within each of the three areas ranged from 0.56 to 0.96 (3 studies with 199 subjects) [23]. Moreover, in another recent study, disease-specific PROMS such as the Southampton Dupuytren's scoring scheme (SDSS) and the URAM did not perform better than hand-specific PROMs, with effect sizes (calculated as mean change in score / baseline SD) of approximately 1.0 for both URAM and SDSS, values substantially lower than those found for COPM in the present study [28]. Finally, the relevance of the URAM in Dupuytren research has been questioned [4].…”

Section: Discussioncontrasting

confidence: 83%

Responsiveness of the patient-specific Canadian occupational performance measure and a fixed-items activity limitations measure in patients with dupuytren disease

Lauritzson

Eckerdal

Atroshi

2023

J Patient Rep Outcomes

View full text Add to dashboard Cite

Background Patients with Dupuytren disease experience various activity limitations. Treatment aims to reduce finger joint contractures to improve hand function and activity performance. For assessing improvement different patient-centered measures have been used. The Canadian Occupational Performance Measure (COPM) was developed as an interview-based outcome measure to detect changes over time in patients’ perception of their performance and satisfaction in self-identified activity issues. The 11-item disabilities of the arm, shoulder and hand (QuickDASH) scale consists of fixed items that ask patients to rate the difficulty in performing specific daily activities. Few studies have compared the responsiveness of these two types of patient-reported measures in Dupuytren disease. Patients and methods We included 30 patients with Dupuytren disease enrolled in a prospective cohort study of collagenase injection. We used the COPM (score range 1–10), the QuickDASH (score range 0-100) and measurement of finger joint contracture before and 5 weeks after treatment. Results Using the COPM the patients identified 107 activity problems (55 in self-care, 19 in productivity and 33 in leisure). The two most common activity problems were to wash self (21 patients) and to don gloves (19 patients). A clinically important improvement with 3 points or greater from baseline to 5 weeks was seen for performance in 77 activities (72%). The median COPM performance score improved from 4.4 at baseline to 9.0 at 5 weeks and the median QuickDASH score improved from 13.6 to 2.5. Responsiveness (Cohen’s d) for the COPM performance was 2.6 (95% CI 1.9–3.3) and for the QuickDASH 0.6 (95% CI 0.1–1.1). Conclusion The COPM had about 6-fold larger responsiveness than the QuickDASH, which supports use of an individualized measure when assessing treatment effects in Dupuytren disease.

show abstract

Section: Discussioncontrasting

confidence: 83%